1[1]Kent DM, Lau J, Selker HP. Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing. Eff Clin Pract. 2001,4(5): 214-220. 被引量：1
5[5]Polonski L, Gasior M, Wasilewski J, et al. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardialinfarction. Am Heart J,2003,145(5): 855-861. 被引量：1
6[6]Hermiller JB, Davidson C J, Aguirre FV, et al. Lesiondirected administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Cathet Cardiovasc Diagn,1996, 37(4): 382-391. 被引量：1
7[7]Pereg D, Behar S, Battler A, et al. Thrombolytic therapy or primary coronary angioplasty in acute myocardial infarction? Israel Thrombolytic Survey Group. Harefuah,2000, 138( 11 ) :939-944. 被引量：1
9[9]Vermeer F, Oude-Ophuis A J, vd Berg EJ, et al.Prospective randomised comparison between thrombolysis,rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospitalwithout PTCA facilities: a safety and feasibility study.1999,82(4): 426-431. 被引量：1
2Tiefenbrunn AJ, Chandra MC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI- 2)[J]. J Am Coll Cardial, 1998, 31:1240-1245. 被引量：1
3The AHAun. Collaboration with the International Liaison Committee on Resuscitation (IL - COR). 7: the ear d reperfusion. Section 1 : acute coronary syndromes (acute myocardial infarctlon)[J]. Circulation, 2000,102(suppl): I- 172- I- 203. 被引量：1
4Nemnann F- J, Kastrati A, Schmitt C, et al. Effect of glycoprotein Ⅱ b/Ⅲ a receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute.myocardial infarction[J]. J Am Coll Cardial, 2000, 35:915-921. 被引量：1
5Morishima I, Sone T, Okumure K, et al. Angiographic no - reflow phenomenon: as a predictor of adverse long- term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction[J]. J Am Coll Cardial, 2000, 36:1202 - 1209. 被引量：1
6Assali AR, Sdringola S, Ghani M, et al. lntracoronary adeno - sine administerd during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no- reflow" phenomenon[J]. Catheter Cardiovasc Interv, 2000, 51:27-31. 被引量：1
7Jeffrey L, Labors A, Lewis C, et al. TIMI petfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction[J]. Circulation, 1993, 87:1829 - 1839. 被引量：1
8Ross AM, Coyne KS, Reiner JS, et al. A randomized trial[J] comparing primary angioplasty with a strategy d short - acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial[J]. J Am Coll Cardial, 1999, 34: 1954- 1962. 被引量：1
9Gibson CM,Cannon CP,Daley WL,et al.TIMI frame count: a quantitative method of assessing coronary artery flow[].Circulation.1996 被引量：1
10Spaulding C,Cador R,Benhamda K,et al.One-week and sixmonth angiographic controls of stent implantation after occlusive and nonocclusive dissection during primary balloon angioplasty for acute myocardial infarction[].The American Journal of Cardiology.1997 被引量：1
3[2]Newby LK,Rutsch WR,Califf RM,et al.For the GUSTO-1 investigators:time from symptom onset to treatment and outcomes after thrombolytic therapy.J Am Coll Cardiol,1996,27:1646-1655. 被引量：1
4[6]The TIMI Research Group.Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction:TIMI Ⅱ A results.JAMA,1988,260:2849-2858. 被引量：1
5[7]Yuzurihara T,Mizuo H,Miyagi Y.Novel modified human tissue plasminogen activators with prolonged plasma clearance in vivo.Thromb Haemost,1989,62:543. 被引量：1
